Journey Medical (DERM) Enterprise Value (2020 - 2026)
Journey Medical (DERM) posted Enterprise Value of -$27.2 million for Q1 2026, down 12.94% on a QoQ basis from -$24.1 million in Q4 2025, and down 29.18% year-over-year from -$38.4 million in Q1 2025.
Journey Medical (DERM) Enterprise Value (2020 - 2026) Analysis & Trends
Journey Medical's Enterprise Value history runs 7 years deep, the most recent figure standing at -$27.2 million for Q1 2026.
- Quarterly Enterprise Value fell 29.18% year-over-year to -$27.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$27.2 million (down 29.18% YoY) and the FY2025 annual result came in at -$24.1 million, down 18.69% from the prior year.
- Enterprise Value was -$27.2 million for Q1 2026 at Journey Medical, down from -$24.1 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$17.0 million in Q2 2023 and bottomed at -$41.3 million in Q1 2022.
- A 5-year average of -$26.5 million and a median of -$24.7 million in 2023 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2022 — Enterprise Value slumped 60.87% — and 2023, when it jumped 55.43%.
- Journey Medical's Enterprise Value stood at -$32.0 million in 2022, then increased by 14.25% to -$27.4 million in 2023, then grew by 26.0% to -$20.3 million in 2024, then retreated by 18.69% to -$24.1 million in 2025, then dropped by 12.94% to -$27.2 million in 2026.
- Business Quant data shows DERM's Enterprise Value at -$27.2 million in Q1 2026, -$24.1 million in Q4 2025, and -$24.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | -1.86 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -3.74 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -1.94 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -4.05 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -2.15 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | -33.59 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -1.80 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -1.32 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -428.00 Mn |
| 10 | Journey Medical | 179.67 Mn | 152.45 Mn | 9.70 Mn | -27.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -27.22 Mn |
| Dec 31, 2025 | -24.10 Mn |
| Sep 30, 2025 | -24.95 Mn |
| Jun 30, 2025 | -20.30 Mn |
| Mar 31, 2025 | -21.07 Mn |
| Dec 31, 2024 | -20.31 Mn |
| Sep 30, 2024 | -22.46 Mn |
| Jun 30, 2024 | -23.90 Mn |
| Mar 31, 2024 | -24.10 Mn |
| Dec 31, 2023 | -27.44 Mn |
| Sep 30, 2023 | -24.75 Mn |
| Jun 30, 2023 | -16.98 Mn |
| Mar 31, 2023 | -26.10 Mn |
| Dec 31, 2022 | -32.00 Mn |
| Sep 30, 2022 | -34.89 Mn |
| Jun 30, 2022 | -38.10 Mn |
| Mar 31, 2022 | -41.30 Mn |
| Dec 31, 2021 | -49.08 Mn |
| Sep 30, 2021 | -21.69 Mn |
| Dec 31, 2020 | -8.20 Mn |